Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. (AURORA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02102165
Recruitment Status : Suspended (suspended temporarily - amending protocol)
First Posted : April 2, 2014
Last Update Posted : July 8, 2021
Sponsor:
Collaborators:
Breast European Adjuvant Studies Team
Frontier Science & Technology Research Foundation, Inc.
Information provided by (Responsible Party):
Breast International Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Actual Primary Completion Date : March 2021
Estimated Study Completion Date : March 2031